Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic rats

Microcirculation

Volumn 17, Issue 6, 2010, Pages 439-446

  Arrick, Denise M ^a   Mayhan, William G ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

ADP; brain; nitroglycerin; NMDA; oxidative stress; superoxide anion

Indexed keywords

ADENOSINE DIPHOSPHATE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GLYCERYL TRINITRATE; N METHYL DEXTRO ASPARTIC ACID; NEURONAL NITRIC OXIDE SYNTHASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN ARTERY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DRUG EFFECT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; OXIDATIVE STRESS; PIA MATER; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ADENOSINE DIPHOSPHATE; ANIMALS; ARTERIOLES; DIABETES MELLITUS, TYPE 1; MALE; N-METHYLASPARTATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDES, CYCLIC; PIA MATER; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; VASODILATION;

RATTUS;

EID: 77955260310     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2010.00042.x     Document Type: Article

References (66)

1. Adner M, You J, Edvinsson L. Characterization of endothelin-A receptors in the cerebral circulation. Neuroreport 4 : 441 443, 1993.
2. Arrick DM, Mayhan WG. Acute infusion of nicotine impairs nNOS-dependent reactivity of cerebral arterioles via an increase in oxidative stress. J Appl Physiol 103 : 2062 2067, 2007.
3. Arrick DM, Sharpe GM, Sun H, Mayhan WG. Diabetes-induced cerebrovascular dysfunction: role of poly(ADP-ribose) polymerase. Microvasc Res 73 : 1 6, 2007.
4. Arrick DM, Sharpe GM, Sun H, Mayhan WG. Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats. Brain Res 1209 : 128 135, 2008.
5. Ayajiki K, Okamura T, Toda N. Involvement of nitric oxide in endothelium-dependent, phasic relaxation caused by histamine in monkey cerebral arteries. Jpn J Pharmacol 60 : 357 362, 1992.
6. Bacic F, Uematsu S, Mccarron RM, Spatz M. Secretion of immunoreactive endothelin-1 by capillary and microvascular endothelium of human brain. Neurochem Res 17 : 699 702, 1992.
7. Brayden JE. Hyperpolarization and relaxation of resistance arteries in response to adenosine diphosphate. Circ Res 69 : 1415 1420, 1991.
8. Cardillo C, Campia U, Bryant MB, Panza JA. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 106 : 1783 1787, 2002.
9. Chrissobolis S, Ziogas J, Chu Y, Faraci FM, Sobey CG. Role of inwardly rectifying K+ channels in K+-induced cerebral vasodilatation in vivo. Am J Physiol 279 : H2704 H2712, 2000.
10. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage arfter intracisternal but not intravenous injection. Life Sci 825 : 834 1629, 1993.
11. Collier A, Leach JP, Mclellan A, Jardine A, Morton JJ, Small M. Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 15 : 1038 1040, 1992.
12. Coppey LJ, Gellett JS, Davidson EP, Yorek MA. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic Res 37 : 33 40, 2003.
13. Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 108 : 1527 1532, 2003. (Pubitemid 37176462)
14. A receptor antagonis LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic Type I diabetes mellitus rat model. J Pharmacol Exp Ther 293 : 351 359, 2000.
15. Dumont AS, Dumont RJ, Mcneill JH, Kassell NF, Sutherland GR, Verma S. Chronic endothelin antagonism restores cerebrovascular function in diabetes. Neurosurgery 52 : 653 660, 2003 discussion 659-660.
16. Fang Q, Sun H, Mayhan WG. Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol 284 : H528 H534, 2003.
17. Faraci FM. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am J Physiol 261 : H1038 H1042, 1991.
18. Faraci FM, Breese KR. Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res 72 : 476 480, 1993.
19. Faraci FM, Breese KR, Heistad DD. Responses of cerebral arterioles to kainate. Stroke 25 : 2080 2084, 1994.
20. Faraci FM, Brian JE. 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to N-methyl-D-aspartate. Stroke 26 : 2172 2176, 1995.
21. Faraci FM, Heistad DD. Role of ATP-sensitive potassium channels in the basilar artery. Am J Physiol 264 : H8 H13, 1993.
22. Francavilla S, Properzi G, Bellini C, Marino G, Ferri C, Santucci A. Endothelin-1 in diabetic and nondiabetic men with erectile dysfunction. J Urol 158 : 1770 1774, 1997.
23. Guvener N, Aytemir K, Aksoyek S, Gedik O. Plasma endothelin-1 levels in non-insulin dependent diabetes mellitus patients with macrovascular disease. Coron Artery Dis 8 : 253 258, 1997.
24. Hadi H, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 3 : 853 876, 2007.
25. Hattori Y, Kawasaki H, Abe K, Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 261 : H1086 H1094, 1991.
26. Hopfner RL, Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications. Diabetologia 42 : 1383 1394, 1999.
27. Kaehler J, Sill B, Koester R, Mittmann C, Orzechowski HD, Muenzel T, Meinertz T. Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species. Clin Sci (Lond) 103 (Suppl 48 176S 178S, 2002.
28. Kanie N, Kamata K. Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat. Br J Pharmacol 135 : 1935 1942, 2002.
29. Khan ZA, Chakrabarti S. Endothelins in chronic diabetic complications. Can J Physiol Pharmacol 81 : 622 634, 2003.
30. Kunz M, Ibrahim S. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm 2009 : 1 20, 2009.
31. Luscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Circulation 108 : 1655 1661, 2003. (Pubitemid 37187795)
32. Luscher TF. Endothelin. J Cardiovasc Pharmacol 18 (Suppl. 10 S15 S22, 1991.
33. Makino A, Kamata K. Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br J Pharmacol 123 : 1065 1072, 1998.
34. Marrelli SP, Khorovets A, Johnson TD, Childres WF, Bryan RM Jr. P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion. Am J Physiol 276 : H33 H41, 1999.
35. Mather KJ, Lteif A, Steinberg HO, Baron AD. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes 53 : 2060 2066, 2004.
36. Mather KJ, Mirzamohammadi B, Lteif A, Steinberg HO, Baron AD. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 51 : 3517 3523, 2002.
37. Mayhan WG, Arrick DM, Sharpe GM, Patel KP, Sun H. Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in Type 1 diabetes mellitus. Microcirculation 13 : 567 575, 2006.
38. Mayhan WG. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am J Physiol 256 : H621 H625, 1989.
39. Mayhan WG. Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vasc Res 29 : 353 358, 1992.
40. Mayhan WG. Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus. Brain Res 580 : 297 302, 1992.
41. Mayhan WG. Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain Res 760 : 204 209, 1997.
42. Mayhan WG, Heistad DD. Permeability of blood-brain barrier to various sized molecules. Am J Physiol 248 : H712 H718, 1985.
43. Miller RC, Pelton JT, Huggins JP. Endothelins - from receptors to medicine. TIPS 14 : 54 60, 1993.
44. Minchenko AG, Stevens MJ, White L, Abatan OI, Komjati K, Pacher P, Szabo C, Obrosova IG. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J 17 : 1514 1516, 2003.
45. Nassar T, Kadery B, Lotan C, Da'As N, Kleinman Y, Haj-Yehia A. Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats. Eur J Pharmacol 436 : 111 118, 2002. (Pubitemid 34142405)
46. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 : 787 790, 2000.
47. Ohishi K, Carmines PK. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol 5 : 1559 1566, 1995.
48. Park J, Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha S, Meier M, Rhodes C, King G. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 49 : 1239 1248, 2000.
49. Pieper GM, Mei DA, Langenstroer P, O'Rourke ST. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am J Physiol Heart Circ Physiol 263 : H676 H680, 1992.
50. Potenza M, Gagliardi S, Nacci C, Carratu' M, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 16 : 94 112, 2009.
51. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46 : 325 415, 1994.
52. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 14 : 83S 89S, 2001.
53. Schneider JG, Tilly N, Hierl T, Sommer U, Hamann A, Dugi K, Leidig-Bruckner G, Kasperk C. Elevated plasma endothelin-1 levels in diabetes mellitus. Am J Hypertens 15 : 967 972, 2002.
54. Sun H, Molacek E, Zheng H, Fang Q, Patel KP, Mayhan WG. Alcohol-induced impairment of neuronal nitric oxide synthase (nNOS)-dependent dilation of cerebral arterioles: role of NAD(P)H oxidase. J Mol Cell Cardiol 40 : 321 328, 2006. (Pubitemid 43152388)
55. Sun H, Patel KP, Mayhan WG. Impairment of neuronal nitric oxide synthase-dependent dilatation of cerebral arterioles during chronic alcohol consumption. Alcohol Clin Exp Res 26 : 663 670, 2002.
56. 2+-dependent K+ channels. Circ Res 76 : 1057 1062, 1995.
57. Tarquini B, Perfetto F, Tarquini R, Cornelissen G, Halberg F. Endothelin-1's chronome indicates diabetic and vascular disease chronorisk. Peptides 18 : 119 132, 1997.
58. Vural P, Cevik A, Curgunlu A, Canbaz M. Effects of diabetes mellitus and acute hypertension on plasma nitric oxide and endothelin concentrations in rats. Clin Chim Acta 320 : 43 47, 2002.
59. Warner TD, Budzik GP, Mitchell JA, Huang ZJ, Murad F. Detection by bioassay and specific enzyme-linked immunoscorbent assay of phosphoramidon- inhibitable endothelin-converting activity in brain and endothelium. J Cardiovasc Pharmacol 20 : S19 S21, 1992.
60. Warner TD, Schmidt HHHW, Kuk J, Mitchell JA, Murad F. Human brain contains a metalloprotease that converts big endothelin-1 to endothelin-1 and is inhibited by phosphoramidon and EDTA. Br J Pharmacol 106 : 505 506, 1992.
61. Woods M, Mitchell J, Wood E, Barker S, Walcot N, Rees G, Warner T. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. Mol Pharmacol 55 : 902 929, 1999.
62. Woods M, Wood E, Mitchell J, Warner T. Signal transduction pathways involved in cytokine stimulation of endothelin-1 release from human vascular smooth muscle cells. J Cardiovasc Pharmacol 36 : S407 S409, 2000.
63. Yamada G, Hama H, Kasuya Y, Masaki T, Goto K. Possible sources of endothelin-1 in damaged rat brain. J Cardiovasc Pharmacol 26 : S486 S490, 1995.
64. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 : 411 415, 1988.
65. Yoshimoto S, Ishizaki Y, Kurihara H, Sasaki T, Yoshizumi M, Yanagisawa M, Yazaki Y, Masaki T, Takakura K, Murota S. Cerebral microvessel endothelium is producing endothelin. Brain Res 508 : 283 285, 1990.
66. 2u receptor-mediated release of endothelium-derived relaxing factor/nitric oxide and endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in rats. Stroke 30 : 1125 1133, 1999.